Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Dec 2;58(6):2101956.
doi: 10.1183/13993003.01956-2021. Print 2021 Dec.

Interstitial lung disease before and after COVID-19: a double threat?

Claudia Valenzuela  1 , Grant Waterer  2 , Ganesh Raghu  3
Affiliations
Editorial

Interstitial lung disease before and after COVID-19: a double threat?

Claudia Valenzuela et al. Eur Respir J. .

Abstract

Pre-existing ILD and pulmonary fibrosis increases the risk to manifest severe COVID-19. Residual interstitial lung changes and sequelae have been observed in COVID-19 survivors. A closer and standardised long-term follow-up of these patients is needed. https://bit.ly/3jWBPCG

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: C. Valenzuela reports personal fees for consultancy and lectures from Boehringer Ingelheim, F. Hoffmann-La Roche, Ltd and BMS, outside the submitted work. Conflict of interest: G. Waterer reports personal fees for consultancy from Union Therapeutics, personal fees for lectures from GSK, outside the submitted work. Conflict of interest: G. Raghu reports personal fees for consultancy from Boehringer Ingelheim, Roche-Genentech and PureTech Health, outside the submitted work.

Comment on

References

    1. World Health Organization . WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/ Date last accessed: 14 May 2021.
    1. Guan W-J, Ni Z-y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 82: 1708–1720. doi: 10.1056/NEJMoa20020. - DOI - PMC - PubMed
    1. Spagnolo P, Balestro E, Aliberti S, et al. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med 2020; 8: 750–752. doi: 10.1016/S2213-2600(20)30222-8). - DOI - PMC - PubMed
    1. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020; 323: 2052–2059. doi: 10.1001/jama.2020.6775. - DOI - PMC - PubMed
    1. Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020; 369: m1985. doi: 10.1136/bmj.m1985 - DOI - PMC - PubMed